| Exclusive Offer: | UK | Europe | RoW | 1 year three-user subscription to SRA:
| £3,170 | €4,860 | $6,355 | | Now you and two colleagues can receive full access to the leading provider of regulatory intelligence for the Pharma and Medtech industries - for the price of just one subscription!
Four easy ways to place your order
1. Call +44 (20) 7017 5540
2. Email regulatory@informa.com and we'll send you an invoice
3. Download an order form
4. If you would like to pay by invoice, bank transfer or cheque, contact:
Drew Edwards
Scrip Regulatory Affairs Account Manager
Tel:+44 (0) 207 017 74400
drew.edwards@informa.com
Request your subscription today! When you subscribe you and two of your colleagues will receive the monthly journal, packed with exclusive features and regulatory guidance, and full access to everything SRA has to offer. All our regulatory guidance, all our powerful search tools and all our time-saving features.
Your subscription will include:
- Full access to all the regulatory news, features, analysis and guidance on the SRA website
- New! Ask The Analyst Service - a unique service that will provide you with specialist regulatory help, build your market intelligence and enhance your strategic planning
- Invaluable daily email alerts of the latest regulatory news and analysis
- Advanced search with personalised emails that automatically updates you the moment new content relevant to your search term is published
- An online searchable PDF library of each issue published since 1992
- An online archive of searchable articles dating back to 2003
- Hypertext links from article references to original source material
- 12 feature-packed monthly issues of the journal, available in print or PDF format
Subscribe to Scrip Regulatory Affairs today to gain access to top quality pharmaceutical and medical devices regulatory guidance from the most trusted and respected experts in the industry.
We're confident Scrip Regulatory Affairs will make an immediate impact on the way you work, minimise compliance costs, mitigate risk and accelerate your time to market.
What is Scrip Regulatory Affairs?
Scrip Regulatory Affairs (SRA) is the leading provider of regulatory news, analysis & practical guidance for the Pharma, Biotech and Medtech industries. SRA helps its readers – your peers and competitors in the Pharma/biotech/medtech industries – avoid costly regulatory mistakes and is an indispensable guide to rules governing the development, launch and post-market surveillance of drugs and medical devices worldwide. Scrip Regulatory Affairs uses a network of experienced, local reporters to provide you with a truly relevant international and independent perspective, keeping readers full informed of the latest developments. Scripregulatoryaffairs.com delivers up-to-the-minute news and analysis on the key regulatory, legal and policy issues facing the global pharma and medtech industries. SRA also publishes a monthly 44-page monthly publication (PDF or hardcopy), providing the month’s key regulatory news, analysis, commentary and practical advice. SRA covers: Regulatory agencies and legislation, marketing application requirements and guidelines, research and development, patents and intellectual property, international harmonisation, drug/medical device safety, pharmacovigilance, pharmacoeconomics,etc.
| What your annual subscription includes
Editorial Board Members Editorial Correspondents __________________
What your peers think of SRA:
"We have had a subscription to [SRA] for 4 years and have just renewed for 2011. I have found it to be the leader of news globally and provides commentary and in depth analysis regarding regulations/ policies/analysis in both the pharmaceutical and biotech arenas. Their delivery and coverage of regulatory information and intelligence is unrivalled in their industry. It is a most critical publication resource piece to assist us in our day to day activities."
Susan A. O’Brien, Manager, Global Regulatory Affairs Johnson & Johnson Pharmaceutical Group __________________
“The updates on global regulatory changes are expanded into useful analysis of how businesses will really be impacted, and interviews with policymakers give readers important insights into future industry developments.” Dr Anne Dupraz Poiseau, Project Director, Medical Devices & Combination Products
Voison Consulting __________________
“[SRA] is the key journal for regulatory professionals working in the global medical device industry. For professionals operating internationally, [SRA] provides that extra bit of intelligence needed to discern the regulatory trends and developments to support regulatory strategies.” M G de Jong,
Medidas Medical Technologies
__________________ |
